Research Achievements
Masaru Taniguchi| 2012 | 2011 | 2010 | 2009 | 2008 |
| Papers| International Conferences |
Papers
Hitomi‚ Y.‚ Ebisawa‚ M.‚ Tomikawa‚ M.‚ Imai‚ T.‚ Komata‚ T.‚ Hirota‚ T.‚ Harada‚ M.‚ Sakashita‚ M.‚ Suzuki‚ Y.‚ Shimojo‚ N.‚ Kohno‚ Y.‚ Fujita‚ K.‚ Miyatake‚ A.‚ Doi‚ S.‚ Enomoto‚ T.‚ Taniguchi‚ M.‚ Higashi‚ N.‚ Nakamura‚ Y.‚ Tamari‚ M. Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma.
J Allergy Clin Immunol 2009; 124 (4): 779-785
Wada H‚ Yasuda T‚ Miura I‚ Watabe K‚ Sawa C‚ Kamijuku H‚ Kojo S‚ Taniguchi M‚ Nishino I‚ Wakana S‚ Yoshida H‚ Seino KI. Establishment of an Improved Mouse Model for Infantile Neuroaxonal Dystrophy That Shows Early Disease Onset and Bears a Point Mutation in Pla2g6.
Am J Pathol. 2009; 175 (6): 2257-2263
Tsunoda I‚ Tanaka T‚ Taniguchi M‚ Fujinami RS. Contrasting roles for Valpha14+ natural killer T cells in a viral model for multiple sclerosis.
J Neurovirol. 2009; 15 (1): 90-98
Tashiro T‚ Nakagawa R‚ Hirokawa T‚ Inoue S‚ Watarai H‚ Taniguchi M‚ Mori K. RCAI-37‚ 56‚ 59‚ 60‚ 92‚ 101‚ and 102‚ cyclitol and carbasugar analogs of KRN7000: their synthesis and bioactivity for mouse lymphocytes to produce Th1-biased cytokines.
Bioorg Med Chem 2009; 17 (17): 6360-6373
Kunii N‚ Horiguchi S‚ Motohashi S‚ Yamamoto H‚ Ueno N‚ Yamamoto S‚ Sakurai D‚ Taniguchi M‚ Nakayama T‚ Okamoto Y. Combination therapy of in vitro-expanded natural killer T cells and ¦Á-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma.
Cancer Sci. 2009; 100 (6): 1092-1098
Motohashi S‚ Nagato K‚ Kunii N‚ Yamamoto H‚ Yamasaki K‚ Okita K‚ Hanaoka H‚ Shimizu N‚ Suzuki M‚ Yoshino I‚ Taniguchi M‚ Fujisawa T‚ Nakayama T. A phase I-II study of ¦Á-Galactosylceramide(KRN7000)-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
J. Immunol. 2009; 182 (4): 2492-2501
International Conferences
Taniguchi M. NKT cells bridging innate and acquired immunity
University of Palermo 2009-9-9 Palermo/Italy
Taniguchi M. A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity.
European Congress on Immunology(ECI¡Ë2009 2009-9-13 Berlin/Germany
Taniguchi M. IL-17RB+ NKT subset responsible for development of AHR
University of Palermo 2009-9-10 Palermo/Italy
Taniguchi M. Islet transplantation
University of Palermo 2009-9-10 Palermo/Italy
Motohashi S‚ Nagato K‚ Taniguchi M‚ Nakayama T‚ Yoshino I. ¦Á-Galactosylceramide-pulsed antigen presenting cell treatment in patients with advanced NSCLC
13th World Conference on Lung Cancer 2009-7-31 San Francisco/U.S.A.
Nagato‚ K.‚ Motohashi‚ S.‚ Yoshino‚ I.‚ Taniguchi‚ M.‚ and Nakayama‚ T. Accumulation of activated V¦Á24 invariant natural killer T cells in the tumor microenvironment after ¦Á-Galactosylceramide-pulsed antigen presenting cell treatment.
The 5th International Symposium on CD1/NKT cells 2009-3-23 Kamakura/Japan
Motohashi S‚ Nagato K‚ Yoshino I‚ Taniguchi M‚ Nakayama T. A Phase I-II study of ¦ÁGalCer-pulsed antigen presenting cells in patients with advanced or recurrent non-small cell lung cancer.
The 5th International Symposium on CD1/NKT Cells 2009-3-23 Kamakura/Japan
Kunii N‚ Motohashi S‚ Yamamoto H‚ Okita K‚ Nagato K‚ Horiguchi S‚ Taniguchi M‚ Okamoto Y‚ Nakayama T. Combination therapy of activated NKT cells and ¦ÁGalCer-pulsed antigen presenting cells in patients with recurrent head and neck cancer.
The 5th International Symposium on CD1/NKT Cells 2009-3-23 Kamakura/Japan
Watarai H‚ Iida M‚ Sakata S‚ Nagata Y‚ Dashtsoodol N‚ Sekine E‚ Inoue S‚ Hongo N‚ Fujii S‚ Shimizu S‚ Kawamoto H‚ Koseki H‚ Taniguchi M. Generation of NKT cells with desired function from embryonic stem cells and induced pluripotent stem cells.
The 5th International Symposium on CD1/NKT Cells 2009-3-23 Kamakura/Japan
Terashima A‚ Watarai H‚ Inoue S‚ Sekine E‚ Nakagawa R‚ Hase K‚ Iwamura C‚ Watarai H‚ Nakayama T‚ Taniguchi M. Novel NKT cell subset bearing IL-17RB is responsible for induction of AHR
The 5th International Symposium on CD1/NKT Cells 2009-3-23 Kamakura/Japan
Tashiro T‚ Inoue S‚ Chiba T‚ Kakimoto K‚ Omori-Miyake M‚ Nakagawa R‚ Fujii S‚ Shimizu K‚ Hirokawa T‚ Watarai H‚ Mori K‚ Taniguchi M. Newly synthesized glycolipids potentiate to produce large amount of IFN-g in vivo
The 5th International Symposium on CD1/NKT Cells 2009-3-23 Kamakura/Japan
Dashtsoodol N‚ Watarai H‚ Sakata S‚ Taniguchi M. The 5th International Symposium on CD1/NKT Cells
The 5th International Symposium on CD1/NKT Cells 2009-3-23 Kamakura/Japan
Watarai H‚ Nagata Y‚ Sakata S‚ Rybouchkin A‚ Koseki H‚ Fujii S‚ Dashtsoodol N‚ Taniguchi M. Generation of NKT cells in vitro from Cloned ES cell line
The 5th International Symposium on CD1/NKT Cells 2009-3-23 Kamakura/Japan
Taniguchi M. Case study:Establishing a translational platform for development of novel therapeutics to allergy in Japan
Biomedical Asia 2009-Translatioonal Research Asia Summit 2009-3-16 Singapore/Singapore
Okamoto Y‚ Kunii N‚ Horiguchi S‚ Uchida T‚ Sakurai D‚ Motohashi S‚ Taniguchi M‚ Nakayama‚ T. Immunotherapy of nasal submucosal injection of ¦Á-Galactosylceramide-pulsed antigen presenting cells or with combination of intra-arterial infusion of activated natural killer T cells in patients with head and neck squamous cell cancer.¡¡
The 1st Chiba University G-COE Symposium‚ 2009-1-6 Tokyo/Japan
